[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
about
Oligometastatic prostate cancer: Metastases-directed therapy?A comprehensive review of contemporary role of local treatment of the primary tumor and/or the metastases in metastatic prostate cancerSurgical resection of urological tumor metastases following medical treatmentPET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Experimental models to study lymphatic and blood vascular metastasis.PET/CT Imaging and Radioimmunotherapy of Prostate CancerPositron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.Clinical oncologic applications of PET/MRI: a new horizon.Modalities for imaging of prostate cancer.Debulking surgery in the setting of very high-risk prostate cancer scenarios.18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.The clinical role of multimodality imaging in the detection of prostate cancer recurrence after radical prostatectomy and radiation therapy: past, present, and futurePET imaging for lymph node dissection in prostate cancer.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Interim analyses in diagnostic versus treatment studies: differences and similaritiesSalvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome.Selective lymph node dissection for castration-resistant prostate cancer.Robotic salvage retroperitoneal and pelvic lymph node dissection for 'node-only' recurrent prostate cancer: technique and initial series.The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapy.Can (68)GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer?Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography.Radiotherapy for isolated lymph node metastases in patients with locally advanced prostate cancer after primary therapy.Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment.
P2860
Q26740069-609E1D6F-97D2-40AC-BA24-DC84F2A2D6C8Q27000180-280B22DD-CD89-4062-8B4E-881F75ECCA7BQ27013035-0CAED545-4368-47C2-8804-ECC94C928E98Q31003607-8BFAFF9B-4D38-41EA-B4DA-FEE6C362B923Q35446777-43F887D9-4F71-4EC2-8097-55EB9A85F39EQ36085426-7C2DC5A4-8FD3-4413-8358-10622265611EQ37457888-A1F1DBA8-368B-4B54-B19D-F42E02977DF1Q37711076-1477A26E-0DBA-4207-9AE8-A2FC5444F071Q37719273-9E14BB29-75EE-443C-9DE4-2E7D67FB4755Q37982152-CC4F21A8-E5D3-4AC6-9E27-A7FECCE167F9Q38098441-12768339-DDA4-46FB-8EC6-82FA247AD65EQ38321182-AC000A53-2BF6-43D1-9527-CB4B53A74F54Q38802235-83E43DA2-AC9E-4A00-AFB5-2D5E7AB1C51FQ38956835-08D52531-6BFB-422D-BFDF-035D7A690B13Q38983526-78639FA9-09F3-4F74-AEAA-658407ADD623Q39242140-839BDC74-6982-4BE4-A2F5-5D1D47811D90Q42410759-52CFACB6-C162-4CB1-A1B5-0F138506F22CQ42785526-CC14989A-2040-4FA3-97E4-00DF95576CB8Q46143507-48384073-BCF8-4D98-931D-27342486E9DEQ51008062-42852C89-BFE0-47CB-8FCA-F6EE4BED23F4Q51073020-19CF4EA4-0A0F-4E0D-BD0D-7F5DE2232F98Q51715242-224FE0E8-A216-457F-BD14-A7E2CD2AE506Q52983462-EBBB47FA-3859-4700-A8A6-6148C2476CE9Q52984262-7C7BE64C-D6DB-4035-A38E-66241DDC01F7Q53031298-0D4BEFB9-8D4B-4149-BD7B-7C86AB21AB04Q53267613-4CBE1C87-FA37-456C-9B8E-0D701F31EAEBQ55188040-53A78843-5043-4066-A6D0-7E112D7C7FEA
P2860
[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
[11C]Choline PET/CT for target ...... esults of a prospective study.
@ast
[11C]Choline PET/CT for target ...... esults of a prospective study.
@en
[11C]Choline PET/CT for target ...... esults of a prospective study.
@nl
type
label
[11C]Choline PET/CT for target ...... esults of a prospective study.
@ast
[11C]Choline PET/CT for target ...... esults of a prospective study.
@en
[11C]Choline PET/CT for target ...... esults of a prospective study.
@nl
prefLabel
[11C]Choline PET/CT for target ...... esults of a prospective study.
@ast
[11C]Choline PET/CT for target ...... esults of a prospective study.
@en
[11C]Choline PET/CT for target ...... esults of a prospective study.
@nl
P2093
P356
P1476
[11C]Choline PET/CT for target ...... esults of a prospective study.
@en
P2093
Bjoern G Volkmer
Felix M Mottaghy
Guenther Egghart
Joerg Simon
Ludwig Rinnab
Markus Wittbrodt
Norbert Blumstein
Peter Moeller
Rainer Kuefer
Richard E Hautmann
P304
P356
10.1159/000144059
P577
2008-08-29T00:00:00Z